Biomatrices for Discovery and Translation.

LEarn more

YOUR CHALLENGE

You are translating your stem cell research result into a cell-based therapies. You face difficulties transferring your proof-of-concept into processes that are compliant with regulatory requirements. Ideally, you would like to maintain the performance of your manufacturing process while using the same components used during the pre-clinical research.

OUR SOLUTION

Our Cell Therapy Grade product line has been developed to serve highest requirements on performance, raw material quality as well as safety and has been developed in accordance with recommendations of European and US Pharmacopoeia on ancillary products.

Schedule a call with us

YOUR BENEFITS

  • Chemical defined – Composed of qualified raw materials at pharma grade

  • Animal Component-Free – Made without animal derived ingredients

  • Expanded Quality Control and Documentation – CoA, CoQ and CoO provided

  • Compliant – Fulfilling pharma grade requirements of USP<1043>

Expansion of MSCs and iPSC for clinical applications – qualify established processes with myMATRIX MSC and iPSC at Cell Therapy Grade.

LET US DO THE HEAVY LIFTING.

We develop, characterize and manufacture extracellular matrix-mimetic coatings for your applications. denovoMATRIX also offers its expertise in cell line establishment, cell expansion and cell analysis to enhance your research and development projects. Contact us for more information on our service and licensing offer.

Schedule a call with us